Nasdaq 100 52-Week Highs & Lows Radar: Electronic Arts, (EA), Monster Beverage (MNST) and more
· Stocks · MarketsFN Team
Nasdaq 100 52-Week Highs & Lows Radar: Electronic Arts, (EA), Monster Beverage (MNST) and more
Screening all 101 Nasdaq 100 constituents for stocks nearest to their 52-week high and their 52-week low. Data as of August 14, 2026. % Realized = 52-week total return.
Legend: RSI > 70 = overbought · RSI < 30 = oversold · Green % Realized = positive 52W return · Red = negative.
📈 Nearest to 52-Week High
Sectors represented: Healthcare (2), Communication Services (1), Consumer Cyclical (1), Technology (1)
| Ticker | Company | Sector | Price Last | % Realized | 52-Week High Date | RSI | % above MA200 | Trend |
|---|---|---|---|---|---|---|---|---|
| EA | Electronic Arts, Inc | Communication Services | $209.70 | +17.14% | 2026-08-04 | 82.2 | +3.5% | Above MA20, MA50, MA200 |
| SBUX | Starbucks Corp | Consumer Cyclical | $108.15 | +16.22% | 2026-08-13 | 59.9 | +12.7% | Above MA20, MA50, MA200 |
| AMGN | AMGEN Inc | Healthcare | $412.31 | +42.03% | 2026-08-13 | 67.5 | +18.0% | Above MA20, MA50, MA200 |
| REGN | Regeneron Pharmaceuticals, Inc | Healthcare | $798.76 | +41.13% | 2026-01-07 | 74.8 | +10.9% | Above MA20, MA50, MA200 |
| PANW | Palo Alto Networks Inc | Technology | $386.61 | +122.77% | 2026-08-13 | 66.9 | +73.8% | Above MA20, MA50, MA200 |
EA | Electronic Arts, Inc | Communication Services | Price Last: $209.70 | % Realized: +17.14% | RSI: 82.2 | % above MA200: +3.5% | Trend: Above MA20, MA50, MA200
Electronic Arts, Inc. develops and publishes interactive entertainment software, known for franchises like FIFA and Madden NFL. Investors should care due to its strong market position and consistent revenue generation from popular gaming titles, which are increasingly integral to digital entertainment.
The current technical situation indicates strong momentum, with an RSI(14) of 82.2 and a bullish MA alignment: price > MA20 > MA50 > MA200. The stock is also 0.0% below its 52-Week high, suggesting a potential breakout.
Related headlines
- EA Brings Madden Bowl to Full Sail University as Madden NFL 27 Championship Series Returns to the University's Campus for Third Consecutive Year
- Akamai beats quarterly estimates on cloud infrastructure demand
- Video game giant Electronic Arts closes $55 billion go-private sale of its business
- PIF, Silver Lake, and Jared Kushner's Affinity Partners complete $55 billion EA deal
SBUX | Starbucks Corp | Consumer Cyclical | Price Last: $108.15 | % Realized: +16.22% | RSI: 59.9 | % above MA200: +12.7% | Trend: Above MA20, MA50, MA200
Starbucks Corp (SBUX) operates a global coffeehouse chain, offering premium coffee, beverages, and food items. Investors should care due to its strong brand loyalty, consistent revenue growth, and expansion strategies that position it well in the competitive food and beverage market.
Currently, SBUX shows bullish momentum with an RSI(14) of 59.9 and a bullish MA alignment: price > MA20 > MA50 > MA200. The stock is also 0.4% below its 52-Week high, indicating potential for further gains.
Related headlines
AMGN | AMGEN Inc | Healthcare | Price Last: $412.31 | % Realized: +42.03% | RSI: 67.5 | % above MA200: +18.0% | Trend: Above MA20, MA50, MA200
AMGEN Inc (AMGN) is a biotechnology company focused on developing innovative therapies for serious illnesses, particularly in oncology and cardiovascular diseases. Investors should care due to its strong pipeline and potential for significant market impact, which can drive revenue growth and shareholder value.
AMGN shows bullish momentum with an RSI(14) of 67.5 and a strong MA alignment: price > MA20 > MA50 > MA200. The stock is also 1.3% below its 52-Week high, indicating a potential breakout level with a 42.0% return over the past year.
Related headlines
REGN | Regeneron Pharmaceuticals, Inc | Healthcare | Price Last: $798.76 | % Realized: +41.13% | RSI: 74.8 | % above MA200: +10.9% | Trend: Above MA20, MA50, MA200
Regeneron Pharmaceuticals, Inc. specializes in developing innovative medicines for serious diseases, including eye disorders, cancer, and inflammatory conditions. Investors should care due to its strong pipeline and potential for significant revenue growth driven by its proprietary drug portfolio.
The current technical situation shows mixed signals with an RSI(14) of 74.8, indicating overbought conditions, while the price is above MA20/MA50/MA200. The stock is 1.7% below its 52-Week high, suggesting a potential breakout level.
Related headlines
- Sanofi to rebuild trust with Regeneron; Apnimed adds to string of upsized biotech IPOs
- Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
- Regeneron Pharmaceuticals Inc (REGN) (Q2 2026) Earnings Call Highlights: Record Dupixent Sales ...
- Regeneron Beats Second-Quarter Expectations as Dupixent Growth Fuels Strong Results
PANW | Palo Alto Networks Inc | Technology | Price Last: $386.61 | % Realized: +122.77% | RSI: 66.9 | % above MA200: +73.8% | Trend: Above MA20, MA50, MA200
Palo Alto Networks Inc specializes in cybersecurity solutions, providing advanced firewalls and cloud-based security services. Investors should care due to the increasing demand for cybersecurity amid rising digital threats, positioning the company for sustained growth and market relevance.
The current technical situation indicates bullish momentum, with an RSI(14) of 66.9 and a strong MA alignment: price > MA20 > MA50 > MA200. The stock is also 2.4% below its 52-Week high.
Related headlines
- Dan Niles Says Workday Deal Could Put A Floor Under Software Stocks Palo Alto CEO Says AI Is No 'Existential Threat' To Cybersecurity
- Why Did PANW, NET, HPQ Stocks Jump To 52-Week Highs Today?
- Why Did PANW, SNOW, EAT Stocks Surge To 52-Week Highs Today?
- Palo Alto Networks Stock Ran On A Threat That Management Had Already Named
📉 Nearest to 52-Week Low
Sectors represented: Consumer Defensive (2), Healthcare (2), Communication Services (1)
| Ticker | Company | Sector | Price Last | % Realized | 52-Week Low Date | RSI | % above MA200 | Trend |
|---|---|---|---|---|---|---|---|---|
| MNST | Monster Beverage Corp | Consumer Defensive | $46.51 | -27.55% | 2026-08-11 | 12.0 | -42.4% | Below MA20, MA50, MA200 |
| PEP | PepsiCo Inc | Consumer Defensive | $140.74 | -5.30% | 2026-07-23 | 53.3 | -5.6% | Above MA20, MA50 · Below MA200 |
| AZN | Astrazeneca plc ADR | Healthcare | $155.20 | -1.11% | 2025-09-25 | 33.2 | -15.8% | Below MA20, MA50, MA200 |
| APP | Applovin Corp | Communication Services | $320.76 | -25.98% | 2026-08-12 | 32.0 | -36.9% | Below MA20, MA50, MA200 |
| IDXX | Idexx Laboratories, Inc | Healthcare | $560.79 | -14.25% | 2026-06-30 | 46.5 | -9.2% | Below MA20, MA50, MA200 |
MNST | Monster Beverage Corp | Consumer Defensive | Price Last: $46.51 | % Realized: -27.55% | RSI: 12.0 | % above MA200: -42.4% | Trend: Below MA20, MA50, MA200
Monster Beverage Corp (MNST) develops and markets energy drinks, including its flagship Monster Energy brand. Investors should care due to its significant market presence and potential for growth in the expanding energy drink sector.
The current technical situation shows a warning sign, with an RSI(14) of 12.0 and mixed signals as the stock is below MA20/MA50/MA200, testing major support just 2.2% above its 52-Week low.
PEP | PepsiCo Inc | Consumer Defensive | Price Last: $140.74 | % Realized: -5.30% | RSI: 53.3 | % above MA200: -5.6% | Trend: Above MA20, MA50 · Below MA200
PepsiCo Inc (PEP) is a global leader in the food and beverage industry, offering a diverse portfolio of brands including snacks, soft drinks, and health-focused products. Investors should care due to its strong market presence and consistent demand for consumer staples, which can provide stability in volatile markets.
Currently, PEP shows mixed technical signals with an RSI(14) of 53.3, indicating neutral momentum. The price is above MA20 and MA50 but below MA200, suggesting potential caution as it tests major support, being only 4.3% above its 52-Week low.
AZN | Astrazeneca plc ADR | Healthcare | Price Last: $155.20 | % Realized: -1.11% | RSI: 33.2 | % above MA200: -15.8% | Trend: Below MA20, MA50, MA200
Astrazeneca plc ADR develops innovative medicines across various therapeutic areas, including oncology and cardiovascular health. Investors should care due to its strong pipeline and potential for growth in high-demand markets, which can drive future revenue and profitability.
The current technical situation indicates a bearish trend, with an RSI(14) of 33.2 and a MA alignment of price < MA20 < MA50 < MA200, suggesting sustained downtrend and caution for investors.
APP | Applovin Corp | Communication Services | Price Last: $320.76 | % Realized: -25.98% | RSI: 32.0 | % above MA200: -36.9% | Trend: Below MA20, MA50, MA200
Applovin Corp (APP) specializes in mobile app marketing and monetization solutions, enabling developers to optimize their advertising strategies and maximize revenue. Investors should care due to its significant role in the growing mobile advertising sector, which is crucial for app developers' success.
Currently, APP shows a bearish technical situation with an RSI(14) of 32.0, indicating oversold conditions. The price is below all moving averages (MA20, MA50, MA200), reflecting a sustained downtrend and testing major support, being only 5.6% above its 52-Week low.
IDXX | Idexx Laboratories, Inc | Healthcare | Price Last: $560.79 | % Realized: -14.25% | RSI: 46.5 | % above MA200: -9.2% | Trend: Below MA20, MA50, MA200
Idexx Laboratories, Inc. specializes in veterinary diagnostics, offering innovative products and services that enhance animal health and improve the quality of care. Investors should care due to its critical role in the growing pet healthcare market, which is increasingly reliant on advanced diagnostic solutions.
The current technical situation shows mixed signals, with an RSI(14) of 46.5 and the stock below MA20/MA50/MA200. Additionally, it is only 6.5% above its 52-Week low, indicating potential warning signs.
Market Commentary
The presence of Nasdaq 100 stocks near 52-week extremes signals a heightened volatility and investor sentiment within the technology sector. Stocks such as EA (Electronic Arts, Inc) and SBUX (Starbucks Corp) are nearing their 52-week highs, indicating strong performance and potential bullish momentum. Conversely, stocks like MNST (Monster Beverage Corp) and PEP (PepsiCo Inc) are positioned above their 52-week lows, suggesting resilience in the face of market pressures.
Several macro themes are influencing these price levels, including ongoing advancements in technology, shifts in consumer behavior, and broader economic conditions. The tech sector has been buoyed by innovations and increased demand for digital solutions, while companies like Starbucks and Regeneron Pharmaceuticals are benefiting from strong brand loyalty and product pipelines. These factors contribute to the performance of stocks near their extremes.
Key levels to watch include the 52-week highs for stocks like EA and SBUX, which could serve as breakout points if surpassed. Conversely, the 52-week lows for stocks such as MNST and PEP may act as critical support levels. Potential catalysts for movement include earnings reports, changes in consumer spending, and macroeconomic indicators that could influence investor sentiment and market dynamics.
Methodology: All 101 Nasdaq 100 constituents screened. 52-week high = highest daily close over the past 252 trading days (approx. 1 year). 52-week low = lowest daily close over the same period. Distance = (current price / extreme − 1) × 100. Technical indicators computed on up to 1 year of daily OHLCV data.
Disclaimer: For informational purposes only. Not investment advice. Past performance is not indicative of future results.